Accessible biosensing Delta Life Science emphasizes affordable, label-free, multiplexed biosensing powered by photonic integrated circuits, presenting a compelling value proposition for cost-conscious laboratories and institutions seeking advanced assay capabilities.

Target diverse customers Its positioning spans academic researchers, assay developers, and pharma scientists, indicating cross-segment opportunities from university labs to CROs and pharma R&D groups needing richer data from precious samples.

Rapid adoption potential With a stated 4x research acceleration and 5x reduction in ownership costs, there is a strong selling point for customers facing tight timelines and high instrument economics.

Spinout credibility As a spinoff of TNO and with a history of platform development, Delta Life Science can leverage credibility, potential partnerships, and access to funding networks to accelerate sales conversations.

Funding and growth signals Revenue in the low-to-mid single digits and a seed-to-early funding round indicate growth potential and a need for strategic customers, channel partnerships, and pilot programs to scale revenue.